If you’re not a cis-gendered female, I don’t see why that article
would color your decision to use Descovy or not. It’s all about the
FDA getting pissed that they didn’t include cis-gendered females in
their study.
Fair enough, but it doesn’t invalidate their findings. It just limits the
generalizations you can make to the population as a whole. There
is little reason to believe it won’t protect cis-gendered females, but
the drug company choose to punt on the topic. Unfortunately, it
looks like the FDA panel is trying to punish them for this, and thus
potentially keeping the drug out of the hands of patients that it
HAS been proven to protect.
It’s gender politics....masquerading as science.